Profitability at CMP Media has improved significantly. An underlying 2 per cent growth in revenue and more than a doubling in operating margins has resulted in operating profits increasing to £11.9m (£4.9m). Underlying technology revenues (over 80 per cent of CMP Media revenues) were up 2 per cent, all media channels achieved positive revenue growth with on line revenues particularly strong with over 30 per cent growth. Five out of the six industry sub-sectors achieved positive growth. Technology publishing yields were up by 3.4 per cent. Last year’s healthcare acquisition (The Oncology Group and Cliggott Publishing) is fully integrated and delivered a good performance. Total healthcare revenues were up over 70 per cent. Underlying revenues were down 3 per cent as publishing again achieved strong growth but revenue from the medical education business (which represents under a quarter of CMP Media’s healthcare business) was reduced as the healthcare companies adapt to new industry regulations. Further operating efficiencies were achieved across CMP Media. In addition, organic investment projects delivered £5.3m of revenue and £1.7m of operating profit. CMP Asia has continued its strong recovery from the negative effects of SARS. Profits of £6.3m reflected improved strength in the established business and growth from products launched in recent years. This active launch programme has continued into 2004. CMP Information has delivered another robust performance. The 2003 acquisitions (including The Builder Group and Barbour Index) are performing well, with significant cost synergies having been achieved. The success of the acquisitions helped drive CMPi’s margins up again – to 20.3 per cent (18.2 per cent). CMPi’s continuing businesses also grew – with underlying revenue up 5.0 per cent. Continuing businesses increased exhibition space, grew yields and – boosted by new product launches – gained market share. UAP’s overall revenue performance was in line with H1’03, with a strong performance from Daltons Weekly and DaltonsBusiness.com, revenue declines from the Exchange & Mart publication and a strong performance from the Auto Exchange titles. Margins were down due to the costs of restructuring, new product investment and promotions. UBM’s acquisition of MediMedia’s drug information businesses in continental Europe and Asia is expected to complete on 30 July 2004. |